Only 3% of patents filed by MNC pharma firms under dispute: Study (Economic Times)
Novartis Loses Patent Appeal for Cancer Medication Glivec (Bloomberg BNA)
India’s Cancer-Drug Ruling Likely to Have Global Impact (Voice of America)
Novartis Loses Patent Bid: Lessons from India’s s(3d) Experience (IP Watch)
India’s Supreme Court to Hear Dispute on Drug Patents
Do Not Push: A Patent Rebellion
Cheap Drugs Pulled Despite Wealth Gap in Middle Income Countries
Trans-Pacific Trade Agreement: GPhA, NGOs Oppose Proposed IP Provisions
Trans-Pacific Partnership Agreement: Did U.S. Move Threaten Public Health?
Indian political will to be put to the test as Cipla seeks Isentress voluntary license